CVSCVS Health
Is it safe?
Solid, nothing alarming. Balance sheet to watch, no accounting flags, quality moderate.
Mixed, watch the balance sheet Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -57% · now 22% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can CVS take a bad year?
CVS Health carries $47.5B of net debt at 3.70× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.70×
Net debt / EBITDA · 3.85× a year ago · the load is coming down
- Altman Z-score
- 2.34
Altman Z-score · grey zone, between 1.8 and 3
- Interest cover
- 2.67×
Interest cover · operating profit covers the interest bill, with room to spare
Details›
- Total debtQ2 2026
- $61.4B
- Cash and short-term investments
- $14.0B
- Net debt
- $47.5B
- EBITDA, trailing twelve months
- $12.8B
- Operating profit, trailing twelve months
- $8.29B
- Debt / equity
- 0.77×
- Total debt / EBITDA
- 4.79×
- Annualised volatilitytwo years of daily moves
- 35%
- Worst drawdown on file
- −57%
- Below its 52-week high
- 22%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.